United States · Bill · S
S. 2814 (117th)
Vital Medication Affordability Act
Introduced
23 September 2021
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Vital Medication Affordability Act This bill establishes pricing for insulin and injectable epinephrine provided at federally qualified health centers (community-based health providers in underserved areas) that participate in the 340B drug pricing program. Specifically, such centers must provide insulin and injectable epinephrine at or below the price paid by the center, plus a minimal administration fee, to patients with a household income that is not more than 350% of the federal poverty level and who either have a health insurance plan with a cost-sharing requirement of more than 20% of the total amount charged for such drugs, have a high unmet deductible under a health insurance plan, or do not have a health insurance plan.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 23 September 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 23 September 2021
Introduced in Senate
summary · EN · 23 September 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/2814
- Open data entity: https://api.congress.gov/v3/bill/117/s/2814